[Drug therapy of supranuclear eye movement disorders].
Neurologische Klinik, Ludwig-Maximilians-Universität München.
A
A
Straube
U
U
Büttner
D000818:Animals; D005133:Eye Movements / Q000502:physiology; D006801:Humans; D009460:Neurologic Examination / Q000379:methods*; D018377:Neurotransmitter Agents / Q000502:physiology; D009759:Nystagmus, Pathologic / Q000188:drug therapy / Q000503:physiopathology; D015835:Ocular Motility Disorders / Q000188:drug therapy* / Q000503:physiopathology; D009802:Oculomotor Nerve / Q000187:drug effects / Q000503:physiopathology; D013494:Supranuclear Palsy, Progressive / Q000188:drug therapy / Q000503:physiopathology; D014795:Visual Pathways / Q000187:drug effects / Q000503:physiopathology
D018377:Neurotransmitter Agents
Medikamentöse Therapie supranukleärer Augenbewegungsstörungen.